Story
Latigo Biotherapeutics Surges 17% in Market Debut After Upsized $346M IPO

Latigo Biotherapeutics Inc. (NASDAQ: LTGO) shares surged 17% in their trading debut Friday after the clinical-stage biopharmaceutical company raised $345.6 million in an upsized initial public offering priced at the top of its expected range.
Upsized Offering Details
The Thousand Oaks, California-based company sold 19.2 million shares at $18 each, according to a company statement. The final pricing came in at the high end of its marketed range of $16 to $18 per share. The offering was also larger than the 16 million shares Latigo had originally planned to sell, indicating robust investor interest.
Underwriters for the deal have a 30-day option to purchase up to an additional 2.88 million shares at the public offering price, less commissions. The offering is expected to close on August 10, subject to customary closing conditions.
Market Performance
AdShares began trading on the Nasdaq Global Select Market under the ticker symbol LTGO, opening at $21 per share. Based on the number of outstanding shares listed in its prospectus, the offering gives Latigo a market capitalization of approximately $1.3 billion.
Company Focus and Pipeline
Latigo Biotherapeutics, backed by Blue Owl Capital Inc., is focused on developing non-opioid analgesics for pain management. The company's pipeline aims to address the need for effective pain relief without the addiction risks associated with opioids.
Its lead product candidate, LTG-001, is an oral Nav1.8 inhibitor being developed for the treatment of acute pain. Goldman Sachs & Co. LLC, Jefferies, Leerink Partners, and Guggenheim Securities served as the joint book-running managers for the offering.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.